By the end of 2019, up to 15 percent of the global healthcare spending is expected to be directed toward value-base...
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at...
VirTrial, a leading telehealth platform provider for virtual clinical trials, has named Amanda Rangel as VP of Business ...
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...
Intensive lowering of blood pressure did not significantly reduce dementia risk but did have a measurable impact on mild...
G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions and GE Healthcare plan to collaborate to i...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...
Abcam, a global innovator in life science reagents and tools has announced its acquisition of Calico Biolabs, a develope...
Roya.com is pleased to announce a new Partnership with Compliancy Group offering medical professionals HIPAA Compliant, ...
Torque, an immuno-oncology company developing first-in-class Deep-Primed T Cell Therapeutics to direct immune power deep...
US based start-up, Day Zero Diagnostics, Inc. (DZD) which is an infectious disease diagnostic company using genome seque...
The British Heart Foundation (BHF) is calling for researchers and innovators from around the world to apply for one...
Merck, a leading science and technology company has announced that it has entered into an exclusive licensing agreement ...
Scientists at deCODE genetics in Iceland, a subsidiary of Amgen has published the first genetic map of the human genome ...
NIH, the African Academy of Sciences, and the Bill & Melinda Gates Foundation are collaborating to establish the Afr...
Eppendorf and the journal Science are now accepting applications for the 2019 Eppendorf & Science Prize for Neurobio...
Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...
Philogen S.p.A., a privately-owned biotechnology company, has announced through its wholly-owned Swiss subsidiary, Philo...
